Population pharmacokinetics of cefotaxime in intensive care patients

被引:0
|
作者
Maria Swartling
Anna-Karin Smekal
Mia Furebring
Miklos Lipcsey
Siv Jönsson
Elisabet I. Nielsen
机构
[1] Uppsala University,Department of Pharmacy
[2] Uppsala University,Department of Surgical Sciences, Anaesthesiology and Intensive Care
[3] Uppsala University,Department of Medical Sciences, Infectious Medicine
来源
European Journal of Clinical Pharmacology | 2022年 / 78卷
关键词
Population pharmacokinetics; Modelling; Cefotaxime; Critically ill;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:251 / 258
页数:7
相关论文
共 50 条
  • [41] Population pharmacokinetics of ciprofloxacin in Pakistani patients suffering from enteric fever
    Saleem, Rabia
    Khan, Humaira Majeed
    Usman, Muhammad
    Khokhar, Muhammad Imran
    Rasheed, Huma
    Abbas, Mateen
    Khan, Rizwan Rasul
    Zaman, Madiha
    Maqsood, Zunair
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (01) : 47 - 54
  • [42] Dose optimization of cefotaxime as pre-emptive treatment in critically ill adult patients: A population pharmacokinetic study
    Roelofsen, Eveline E.
    Abdulla, Alan
    Muller, Anouk E.
    Endeman, Henrik
    Gommers, Diederik
    Dijkstra, Annemieke
    Hunfeld, Nicole G. M.
    de Winter, Brenda C. M.
    Koch, Birgit C. P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (02) : 705 - 713
  • [43] Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation
    Revilla, Natalia
    Martin-Suarez, Ana
    Paz Perez, Marta
    Martin Gonzalez, Felix
    del Mar Fernandez de Gatta, Maria
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (02) : 201 - 212
  • [44] External Evaluation of Population Pharmacokinetic Models of Vancomycin in Large Cohorts of Intensive Care Unit Patients
    Guo, Tingjie
    van Hest, Reinier M.
    Roggeveen, Luca F.
    Fleuren, Lucas M.
    Thoral, Patrick J.
    Bosman, Rob J.
    van der Voort, Peter H. J.
    Girbes, Armand R. J.
    Mathot, Ron A. A.
    Elbers, Paul W. G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [45] Who should care for intensive care unit patients?
    Gutsche, Jacob T.
    Kohl, Benjamin A.
    CRITICAL CARE MEDICINE, 2007, 35 (02) : S18 - S23
  • [46] Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients
    Li, Xingang
    Wu, Yuanxing
    Sun, Shusen
    Mei, Shenghui
    Wang, Jiaqing
    Wang, Qiang
    Zhao, Zhigang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (11) : 3960 - 3967
  • [47] Population Pharmacokinetics of Ganciclovir in Critically Ill Patients
    Krens, Stefanie D.
    Hodiamont, Caspar J.
    Juffermans, Nicole P.
    Mathot, Ron A. A.
    van Hest, Reinier M.
    THERAPEUTIC DRUG MONITORING, 2020, 42 (02) : 295 - 301
  • [48] Population pharmacokinetics of infliximab in patients with ankylosing spondylitis
    Xu, Zhenhua
    Seitz, Kathleen
    Fasanmade, Adedigbo
    Ford, Joyce
    Williamson, Paul
    Xu, Weichun
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (06) : 681 - 695
  • [49] Population pharmacokinetics of daptomycin in critically ill patients
    Soraluce, A.
    Asin-Prieto, E.
    Rodriguez-Gascon, A.
    Barrasa, H.
    Maynar, J.
    Carcelero, E.
    Soy, D.
    Isla, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (02) : 158 - 165
  • [50] Comparative pharmacokinetics of cefotaxime in normal cyclic and endometritis affected buffaloes
    Singh, S
    Gandotra, VK
    Sharma, SK
    Srivastava, AK
    INDIAN JOURNAL OF ANIMAL SCIENCES, 2005, 75 (12) : 1368 - 1371